Skip to main content
Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
0.555
+0.055 (10.90%)
At close: Mar 9, 2026, 4:00 PM EDT
0.544
-0.012 (-2.09%)
After-hours: Mar 9, 2026, 6:16 PM EDT

Gossamer Bio Revenue

Gossamer Bio had revenue of $13.29M in the quarter ending September 30, 2025, with 40.23% growth. This brings the company's revenue in the last twelve months to $44.05M, down -58.17% year-over-year. In the year 2024, Gossamer Bio had annual revenue of $114.70M.

Revenue (ttm)
$44.05M
Revenue Growth
-58.17%
P/S Ratio
2.92
Revenue / Employee
$303,800
Employees
145
Market Cap
128.53M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024114.70M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Codexis 52.93M
Equillium 4.39M
Coya Therapeutics 3.99M
Precision BioSciences 698.00K
Inovio Pharmaceuticals 182.34K
Genelux 8.00K
Revenue Rankings

GOSS News

More News